Health ❯ Mental Health ❯ Schizophrenia

Treatment Options

Antipsychotic Medications Public Awareness Crisis Intervention Institutionalization Long-acting Injectables Clinical Trials Stigma Reduction Long-Acting Injectables Cobenfy Crisis Management Patient Adherence Impact on Behavior Psychiatric Evaluation Drug Efficacy Societal Impact Public Health Policy Personal Stories Medication New Treatments

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Vanda secured clearance using bridged iloperidone evidence to speed the review.

Parkland Survivor Donovan Metayer, 26, Dies by Suicide After Risk Order Lapses

FDA Clears Monthly Uzedy Injection for Maintenance Treatment of Bipolar I Disorder